These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23939334)

  • 1. SYNTAX from the evidence to the disobedience.
    Buffolo E; Stein AJ
    Rev Bras Cir Cardiovasc; 2013 Jun; 28(2):III-V. PubMed ID: 23939334
    [No Abstract]   [Full Text] [Related]  

  • 2. The FREEDOM trial: a definitive answer to coronary artery bypass grafting or stents in patients with diabetes and multivessel coronary artery disease.
    Taggart DP
    Eur J Cardiothorac Surg; 2013 Dec; 44(6):978-9. PubMed ID: 24047712
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Choi JW; Ruzyllo W; Religa G; Huang J; Roy K; Dawkins KD; Mohr F
    Circulation; 2014 Jun; 129(23):2388-94. PubMed ID: 24700706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of everolimus-eluting stents versus first-generation drug-eluting stents in patients with left main coronary artery undergoing percutaneous coronary intervention.
    Capodanno D; Capranzano P; La Manna A; Tamburino C
    Int J Cardiol; 2013 Sep; 168(2):1718-9. PubMed ID: 23642615
    [No Abstract]   [Full Text] [Related]  

  • 8. Are drug-eluting stents superior to bare metal stents when compared to coronary artery bypass surgery? Show me the data.
    Rodriguez AE
    Cardiovasc Revasc Med; 2013; 14(2):90-2. PubMed ID: 23290662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CABG not PCI for most people with complex coronary artery disease.
    BMJ; 2013 Feb; 346():f1289. PubMed ID: 23447349
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: an updated meta-analysis of 4 randomized, controlled trials.
    Benedetto U; Ng C; Smith R; Raja SG;
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2430-2. PubMed ID: 25224547
    [No Abstract]   [Full Text] [Related]  

  • 11. The future of interventional cardiology.
    White CJ
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):4-5. PubMed ID: 23281080
    [No Abstract]   [Full Text] [Related]  

  • 12. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main and Multivessel Coronary Artery Disease: Do We Have the Evidence?
    Gersh BJ; Stone GW; Bhatt DL
    Circulation; 2017 Feb; 135(9):819-821. PubMed ID: 28242636
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the Syntax score II and its principles behind it applicable to the entire spectrum of the real world practice?
    Parissis H
    Int J Cardiol; 2016 Jul; 214():13-5. PubMed ID: 27055159
    [No Abstract]   [Full Text] [Related]  

  • 15. The SYNTAX trial: a perspective.
    Gulati R; Rihal CS; Gersh BJ
    Circ Cardiovasc Interv; 2009 Oct; 2(5):463-7. PubMed ID: 20031757
    [No Abstract]   [Full Text] [Related]  

  • 16. Minimally invasive direct coronary artery bypass reduces the need for repeated revascularization at long-term follow-up compared with stenting: a meta-analysis.
    Zhang B; Zhou J; Li H; Zhou M; Chen A; Zhao Q
    Int J Cardiol; 2013 Oct; 168(6):5469-71. PubMed ID: 23988305
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of three-year outcomes after coronary stenting versus coronary artery bypass grafting in patients with multivessel coronary disease, including involvement of the left anterior descending coronary artery proximally (a subanalysis of the arterial revascularization therapies study trial).
    Aoki J; Ong AT; Arampatzis CA; Vijaykumar M; Rodriguez Granillo GA; Disco CM; Serruys PW
    Am J Cardiol; 2004 Sep; 94(5):627-31. PubMed ID: 15342295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ; Head SJ; Holmes DR; Ståhle E; Feldman TE; Colombo A; Morice MC; Unger F; Erglis A; Stoler R; Dawkins KD; Serruys PW; Mohr FW; Kappetein AP
    JACC Cardiovasc Interv; 2013 Apr; 6(4):344-54. PubMed ID: 23523456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease.
    Gössl M; Faxon DP; Bell MR; Holmes DR; Gersh BJ
    Circ Cardiovasc Interv; 2012 Aug; 5(4):597-604. PubMed ID: 22896575
    [No Abstract]   [Full Text] [Related]  

  • 20. Give me FREEDOM or..
    King SB
    JACC Cardiovasc Interv; 2012 Nov; 5(11):1190-1. PubMed ID: 23174648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.